Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Metabolism

Sex-Specific Control of Fat Mass and Counterregulation by Hypothalamic Glucokinase

  1. Laura K.M. Steinbusch,
  2. Alexandre Picard,
  3. Marion S. Bonnet,
  4. Davide Basco,
  5. Gwenaël Labouèbe and
  6. Bernard Thorens⇑
  1. Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland
  1. Corresponding author: Bernard Thorens, bernard.thorens{at}unil.ch.
Diabetes 2016 Oct; 65(10): 2920-2931. https://doi.org/10.2337/db15-1514
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Inactivation of the Gck gene in Sf1 neurons. A: Structure of the Gck gene, the targeting vector, the floxed Gck allele after flp-mediated removal of the puromycin (Puro) gene, and the recombined Gck allele following Cre-dependent recombination (KO allele). Location of the primers for genotyping are indicated by arrows. B: Brightfield and fluorescence microscopy images of a brain section of an Sf1-Cre;Rosa26tdtomato;Gck+/+ mouse. The VMN (dashed line) and ARC (dotted line) are indicated. C: Following laser-capture microdissection of the VMN or ARC from brains of Sf1-Cre;ROSA26tdtomato;Gck+/+ (Ctrl) and Sf1-Cre;ROSA26tdtomato;Gcklox/lox (KO) mice, RNA was extracted and Gck mRNA was quantified by quantitative RT-PCR analysis. Data are normalized to β-actin expression and set at 1 for VMN Ctrl. nd, not detectable. D: In situ hybridization detection of Gck on coronal hypothalamic sections (Bregma −1.7). Gck was not detected in the VMN (dashed line) of Sf1Gck−/− (KO) mice but was still present in the ARC (dotted line).

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Increased adiposity in female but not male Sf1Gck−/− mice fed a normal chow. A and B: Female and male Ctrl and Sf1Gck−/− (KO) mice were fed normal chow, and their body weight was monitored over 20 weeks (n = 12–20 mice per group). C–F: Fat (C and E) and lean mass (D and F) were measured by EchoMRI in female and male Ctrl and KO mice at 12 and 24 weeks of age (n = 12–20 mice per group). G–I: Gonadal fat (G), inguinal fat (H), and brown adipose tissue (BAT) (I) weights in 26-week-old mice (n = 12–20 mice). J and K: Indirect calorimetry measurement of heat production in female (J) and male (K) Ctrl and KO mice (n = 5–6 mice). hr, hour; ON, overnight. Evaluations used 2-way ANOVA (A and B) and the Student t test (C–K). *P < 0.05; ** P < 0.01; *** P < 0.001.

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    Increased adipocyte size in 26-week-old Sf1Gck−/− female mice fed normal chow. Histological sections of gonadal (A) and inguinal (B) fat of Ctrl and Sf1Gck−/− (KO) mice. C and D: Adipocyte size distribution in gonadal (C) and inguinal (D) fat depots of female mice (n = 4, 7–16 images per mouse). E and F: Adipocyte size distribution in gonadal (E) and inguinal (F) fat depots of male mice. Lipolytic and lipogenic gene expression in gonadal (G) and inguinal WAT (H) of female Ctrl and KO mice (n = 7–8 mice). Evaluations used 2-way ANOVA (C–F) and the Student t test (G and H). *P < 0.05; **P < 0.01; ***P < 0.001.

  • Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4

    Normal glucose homeostasis in Sf1Gck−/− mice. Blood glucose in random-fed (A) and overnight (ON)-fasted (B) Ctrl and Sf1Gck−/− (KO) mice at 24 weeks of age. Plasma insulin concentrations in random-fed (C) and ON-fasted (D) Ctrl and KO mice at 27 weeks of age. The same mice displayed a normal intraperitoneal glucose tolerance test (2g/kg) (E and F). n = 8–12 mice. Evaluations used the Student t test (A–D) or 2-way ANOVA (E and F). *P < 0.05.

  • Figure 5
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5

    Lower glucagon secretion in response to hypoglycemia in female Sf1Gck−/− mice. Blood glucose (A, females; C, males) and plasma glucagon concentrations (B, females; D, males) 1 h after an intraperitoneal injection of saline or insulin (0.3–0.7 U/kg) in Ctrl and Sf1Gck−/− (KO) mice (18–31 weeks old; n = 12–32). E and F: Plasma epinephrine and norepinephrine 1 h after insulin injection to induce hypoglycemia (0.6 U/kg) in 18-week-old female Ctrl and KO mice. G: Blood glucose concentrations during a hypoglycemic-hyperinsulinemic clamp in female Ctrl and KO mice. H: Plasma glucagon concentrations at the end of the clamp (n = 7–8 mice, 18 weeks of age). I: Pancreatic glucagon content (n = 5–6 mice). J: Overnight-fasted plasma glucagon concentrations (n = 9–14 mice). Two-way ANOVA (A–F) and the Student t test (H–J) were used; the effect of insulin is significant in all experiments. *P < 0.05; **P < 0.01.

  • Figure 6
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6

    No induction of parasympathetic and sympathetic nerve activity by neuroglucopenia in female Sf1Gck−/− mice. A: Parasympathetic nerve activity recordings in Ctrl and Sf1Gck−/− (KO) mice in the basal state and after 2DG injection (600 mg/kg i.p.). B: Sympathetic nerve activity recordings in Ctrl and KO mice in the basal state and after intraperitoneal 2DG injection. C–F: Quantification of the firing rates of the parasympathetic (C and E) and sympathetic (D and F) nerve activities in female and male mice (n = 5–10 mice, 12 weeks of age). sec, second. Two-way ANOVA was used. *P < 0.05; **P < 0.01; ***P < 0.001.

  • Figure 7
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7

    Gck is not required for the glucose responsiveness of Sf1 GE and GI neurons. Whole-cell patch clamp recordings on Sf1 neurons from Sf1-Cre;ROSA26tdtomato;Gck+/+ (Ctrl) and Sf1-Cre;ROSA26tdtomato;Gcklox/lox (KO) mice. A and B: GI neuron activation by 0.1 mmol/L glucose is detected in Ctrl (A) and KO (B) Sf1 neurons. Similarly, inhibition of GE neurons by 0.1 mmol/L glucose is observed in both Ctrl (C) and KO (D) Sf1 neurons.

Tables

  • Figures
  • Table 1

    Whole-cell patch clamp recordings of Sf1 neurons from Sf1-Cre;ROSA26tdtomato;Gck+/+ (Ctrl) and Sf1-Cre;ROSA26tdtomato;Gcklox/lox (KO) mice show a similar distribution of GI, GE, and nonresponder neurons in male and female mice

    Ctrl miceKO miceNon-Sf1 neurons in the VMN* (female and male)
    FemaleMaleFemaleMale
    GI neurons35863
    GE neurons67864
    Nonresponder neurons357414
    Total1217231621
    • Data are n.

    • *Non-Sf1 neurons in the VMN were mainly nonresponder neurons.

PreviousNext
Back to top
Diabetes: 65 (10)

In this Issue

October 2016, 65(10)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Sex-Specific Control of Fat Mass and Counterregulation by Hypothalamic Glucokinase
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Sex-Specific Control of Fat Mass and Counterregulation by Hypothalamic Glucokinase
Laura K.M. Steinbusch, Alexandre Picard, Marion S. Bonnet, Davide Basco, Gwenaël Labouèbe, Bernard Thorens
Diabetes Oct 2016, 65 (10) 2920-2931; DOI: 10.2337/db15-1514

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Sex-Specific Control of Fat Mass and Counterregulation by Hypothalamic Glucokinase
Laura K.M. Steinbusch, Alexandre Picard, Marion S. Bonnet, Davide Basco, Gwenaël Labouèbe, Bernard Thorens
Diabetes Oct 2016, 65 (10) 2920-2931; DOI: 10.2337/db15-1514
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Research Design and Methods
    • Results
    • Discussion
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Ncor2/PPARα-Dependent Upregulation of MCUb in the Type 2 Diabetic Heart Impacts Cardiac Metabolic Flexibility and Function
  • Role of the Neutral Amino Acid Transporter SLC7A10 in Adipocyte Lipid Storage, Obesity, and Insulin Resistance
  • Heme Oxygenase-1 Regulates Ferrous Iron and Foxo1 in Control of Hepatic Gluconeogenesis
Show more Metabolism

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.